Inhibrx Biosciences Inc (INBX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 226,860 | 252,483 | 277,924 | 337,327 | 192,492 |
| Receivables | 1,387 | 3,038 | 778 | 331 | 327 |
| TOTAL | $242,057 | $274,538 | $295,358 | $363,297 | $203,321 |
| Non-Current Assets | |||||
| PPE Net | 7,605 | 6,966 | 6,419 | 2,864 | 2,832 |
| Other Non-Current Assets | 8,756 | 7,073 | 6,116 | 6,572 | 7,017 |
| TOTAL | $16,361 | $14,039 | $12,535 | $9,436 | $9,849 |
| Total Assets | $258,418 | $288,577 | $307,893 | $372,733 | $213,170 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 3,632 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 13,021 | 14,792 | 10,954 | 7,858 | 9,700 |
| Accrued Expenses | 23,860 | 51,329 | 43,295 | 25,902 | 19,551 |
| TOTAL | $39,052 | $71,870 | $56,312 | $35,771 | $31,329 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 204,578 | 206,968 | 205,721 | 204,482 |
| Deferred Revenues | N/A | N/A | N/A | N/A | 119 |
| Other Non-Current Liabilities | 0 | 561 | 1,110 | 1,646 | 0 |
| TOTAL | $N/A | $205,139 | $208,078 | $207,367 | $206,653 |
| Total Liabilities | $39,052 | $277,009 | $264,390 | $243,138 | $237,982 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 14,476 | 52,402 | 47,392 | 47,291 | 43,668 |
| Common Shares | 1 | 5 | 5 | 5 | 4 |
| Retained earnings | -14,403 | -692,444 | -613,734 | -520,130 | -468,341 |
| TOTAL | $219,366 | $11,568 | $43,503 | $129,595 | $-24,812 |
| Total Liabilities And Equity | $258,418 | $288,577 | $307,893 | $372,733 | $213,170 |